XML 24 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Associations of Unit Owners
Cumulative Effect, Period of Adoption, Adjustment
[5]
Total Stockholders' Equity
Total Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
[5]
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
[5]
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Noncontrolling Interests
Noncontrolling Interests
Associations of Unit Owners
Balance at the beginning of the period (in shares) at Dec. 31, 2019           43,635,893              
Balance at the beginning of the period at Dec. 31, 2019 $ 3,332,988     $ 3,148,133   $ 437 $ 3,343,983 $ (46,385)   $ (29,372) $ (120,530) $ 184,855  
Balance at the beginning of the period (in shares) at Dec. 31, 2019                     (1,050,260)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) excluding income (loss) attributable to redeemable noncontrolling interest (26,054)     (26,154)       (26,154)       100  
Interest rate swaps, net of tax (23,070) [1]     (23,070)           (23,070)      
Pension adjustment, net of tax (84) [2]     (84)           (84)      
Reclassification of redeemable noncontrolling interest to temporary equity (6,091)                     (6,091)  
Share of investee's other comprehensive income, net of tax expense (benefit) 1,002 [3]     1,002           1,002      
Derecognition of 110 North Wacker, net of tax of $951 [4] $ (165,509)     12,935       1   12,934   (178,444)  
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]                        
Issuance of common shares (in shares)           12,270,900              
Issuance of common shares $ 593,616     593,616   $ 123 593,493            
Stock plan activity (in shares)           136,021         (20,298)    
Stock plan activity 8,243     8,243   $ 2 9,802       $ (1,561)    
Balance at the end of the period (in shares) at Dec. 31, 2020           56,042,814              
Balance at the end of the period at Dec. 31, 2020 3,715,023   $ (18) 3,714,603 $ (18) $ 562 3,947,278 (72,556) $ (18) (38,590) $ (122,091) 420  
Balance at the end of the period (in shares) at Dec. 31, 2020                     (1,070,558)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) excluding income (loss) attributable to redeemable noncontrolling interest 56,355     56,100       56,100       255  
Interest rate swaps, net of tax 17,960 [1]     17,960           17,960      
Pension adjustment, net of tax 452 [2]     452           452      
Share of investee's other comprehensive income, net of tax expense (benefit) 5,721 [3]     5,721           5,721      
Issuance of common shares (5)     (5)     (5)            
Repurchase of common shares (in shares)                     (1,023,284)    
Repurchase of common shares (96,620)     (96,620)             $ (96,620)    
Stock plan activity (in shares)           130,462         (13,773)    
Stock plan activity $ 11,784     11,784   $ 1 13,145       $ (1,362)    
Balance at the end of the period (in shares) at Dec. 31, 2021 54,065,661         56,173,276              
Balance at the end of the period at Dec. 31, 2021 $ 3,710,670     3,709,995   $ 563 3,960,418 (16,456)   (14,457) $ (220,073) 675  
Balance at the end of the period (in shares) at Dec. 31, 2021 (2,107,615)                   (2,107,615)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                          
Net income (loss) excluding income (loss) attributable to redeemable noncontrolling interest $ 184,636     184,533       184,533       103  
Interest rate swaps, net of tax 31,698 [1]     31,698           31,698      
Pension adjustment, net of tax (183) [2]     (183)           (183)      
Deconsolidation of Ward Village homeowners’ associations   $ (211)                     $ (211)
Issuance of Teravalis noncontrolling interest 65,046                     65,046  
Reclassification of the Company’s share of previously deferred derivative gains, net of tax expense [6] (6,723)     (6,723)           (6,723)      
Share of investee's other comprehensive income, net of tax expense (benefit) [3] 0                        
Repurchase of common shares (in shares)                     (4,283,874)    
Repurchase of common shares (388,372)     (388,372)             $ (388,372)    
Stock plan activity (in shares)           52,997         (32,787)    
Stock plan activity $ 9,551     9,551   $ 1 12,143       $ (2,593)    
Balance at the end of the period (in shares) at Dec. 31, 2022 49,801,997         56,226,273              
Balance at the end of the period at Dec. 31, 2022 $ 3,606,112     $ 3,540,499   $ 564 $ 3,972,561 $ 168,077   $ 10,335 $ (611,038) $ 65,613  
Balance at the end of the period (in shares) at Dec. 31, 2022 (6,424,276)                   (6,424,276)    
[1] Amounts are shown net of deferred tax expense of $9.5 million for the year ended December 31, 2022, deferred tax expense of $5.1 million for the year ended December 31, 2021, and deferred tax benefit of $5.3 million for the year ended December 31, 2020.
[2] The deferred tax impact was not meaningful for the years ended December 31, 2022, 2021 and 2020.
[3] Amounts are shown net of deferred tax expense of $1.6 million for the year ended December 31, 2021, and $0.3 million for the year ended December 31, 2020.
[4] Related to deconsolidation of 110 North Wacker. Refer to Note 2 - Investments in Unconsolidated Ventures for additional information.
[5] Related to the adoption of ASU 2016-13, Financial Instruments-Credit Losses (Topic 326) and its related amendments.
[6] In March 2022, the Company completed the sale of its ownership interest in 110 North Wacker and released a net of $6.7 million from Accumulated other comprehensive income (loss), representing the Company’s $8.6 million share of previously deferred gains associated with the Venture’s derivative instruments net of tax expense of $1.9 million. See Note 2 - Investments in Unconsolidated Ventures for additional information.